- 3 hours ago
Unexpected role of OTX2 drives aggressive medulloblastoma
Researchers revealed an unexpected way in which the protein OTX2 drives the progression of medulloblastoma -- the most common aggressive...
- 1 day ago
Pharmacotyping provides a precision medicine blueprint for acute lymphoblastic leukemia treatment
In a report published in Nature Medicine, St. Jude scientists examined how ALL cells respond to different therapeutics in the context of...
- 2 days ago
Gain-of-function mutation reveals new target in pediatric acute myeloid leukemia
Pediatric acute myeloid leukemia (AML) accounts for 20% of all pediatric leukemia cases and is associated with poor outcomes, especially...
- 3 days ago
Proton therapy improves neurocognitive outcomes of childhood craniopharyngioma
In a recent phase 2 clinical trial for children with craniopharyngioma, researchers at St. Jude found that photon therapy and the more...
- 4 days ago
Assembling a molecular mosaic for pediatric brain tumors
With a focus on translational research that grounds new clinical developments in the latest laboratory science, St. Jude is advancing the...
- Jul 18
This kids’ brain cancer is incurable — but immune therapy holds promise
CAR-T therapy, which harnesses a person’s own immune cells, racks up some astonishing success stories against deadly brain tumours in...
- Jul 17
Research takes on the long-term health of childhood cancer survivors
New research from the University of Alberta offers the hope of better long-term outcomes for survivors of childhood cancer—and the path...
- Jul 16
Stem-like cells found to drive growth of aggressive pediatric brain tumors
A team of researchers at Baylor College of Medicine, Texas Children's Hospital, the Hospital for Sick Children in Toronto and...